Category Archives: Research and Development

HVTN 505 Investigator: “We’ve got to keep moving the stone up the hill”

By on .

A week to the day after a monitoring board told organizers of the clinical vaccine research trial known as HVTN 505 to stop inoculating participants, only a few certainties have surfaced. One is that the would be vaccine regimen did not prevent HIV infections. The other is that the search for an effective vaccine will […]

Disappointing vaccine trial news, key populations, PEPFAR blueprint all part of Jhpiego’s “The Present and the Future of HIV Prevention”

By on .

A chart of clinical research trials seeking ways to control HIV transmission makes for an impressive display of tenacity, with interrupted trials, ongoing trials, trials that led to other trials, and new trials in their earliest stages. It includes trials of microbicides, vaccines, antiretroviral-drug-based approaches and all of that in different combinations. It includes heartening […]

Bill would acknowledge, sustain USAID role in global health research and development

By on .

At a time when global health responses are threatened by budget-cutting fever, a “deficit neutral” bill proposed by Rep. Albio Sires (D-NJ), and Rep. Mario Diaz-Balart (R-FL) would create a comprehensive strategy to get the most out of a government investment with some of the biggest returns: global health research and development. The 21rst Century […]

How the Medicines Patent Pool expands access to live-saving HIV treatment

By on .

At last week’s Global Aids Policy Partnership meeting, representatives from the Medicines Patent Pool gave a presentation on their organization, which works to expand access to life-saving antiretroviral (ARV) medicines in the developing world by working with patent holders to negotiate licenses for key HIV medicines patents.  This allows generic drug companies to produce high […]

AVAC talk: As headlines raise hopes, cure researchers manage expectations and challenges

By on .

There was a time, not long ago, that talk of a cure for HIV was so unrealistic that the topic was all but taboo. More recently talk of an HIV cure is the topic of headlines. First came Timothy Brown, “the Berlin Patient,” free of replicable HIV for more than half a dozen years, since […]